296 related articles for article (PubMed ID: 11220738)
1. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy.
van Geel BM; Bezman L; Loes DJ; Moser HW; Raymond GV
Ann Neurol; 2001 Feb; 49(2):186-94. PubMed ID: 11220738
[TBL] [Abstract][Full Text] [Related]
2. [X-linked adrenoleukodystrophy].
Aubourg P
Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
[TBL] [Abstract][Full Text] [Related]
3. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
[TBL] [Abstract][Full Text] [Related]
4. MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy.
Fatemi A; Barker PB; Uluğ AM; Nagae-Poetscher LM; Beauchamp NJ; Moser AB; Raymond GV; Moser HW; Naidu S
Neurology; 2003 Apr; 60(8):1301-7. PubMed ID: 12707433
[TBL] [Abstract][Full Text] [Related]
5. Seven-Tesla proton magnetic resonance spectroscopic imaging in adult X-linked adrenoleukodystrophy.
Ratai E; Kok T; Wiggins C; Wiggins G; Grant E; Gagoski B; O'Neill G; Adalsteinsson E; Eichler F
Arch Neurol; 2008 Nov; 65(11):1488-94. PubMed ID: 19001168
[TBL] [Abstract][Full Text] [Related]
6. Brain MRI and electrophysiologic abnormalities in preclinical and clinical adrenomyeloneuropathy.
Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Lemaitre A; Boureau F; Mayer M; Kalifa G
Neurology; 1992 Jan; 42(1):85-91. PubMed ID: 1734328
[TBL] [Abstract][Full Text] [Related]
7. Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds.
van Geel BM; Assies J; Weverling GJ; Barth PG
Neurology; 1994 Dec; 44(12):2343-6. PubMed ID: 7991123
[TBL] [Abstract][Full Text] [Related]
8. Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy.
Eichler FS; Barker PB; Cox C; Edwin D; Ulug AM; Moser HW; Raymond GV
Neurology; 2002 Mar; 58(6):901-7. PubMed ID: 11914405
[TBL] [Abstract][Full Text] [Related]
9. MR spectroscopic imaging of normal-appearing white matter in adrenoleukodystrophy.
Izquierdo M; Adamsbaum C; Benosman A; Aubourg P; Bittoun J
Pediatr Radiol; 2000 Sep; 30(9):621-9. PubMed ID: 11009301
[TBL] [Abstract][Full Text] [Related]
10. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy.
Pujol A; Hindelang C; Callizot N; Bartsch U; Schachner M; Mandel JL
Hum Mol Genet; 2002 Mar; 11(5):499-505. PubMed ID: 11875044
[TBL] [Abstract][Full Text] [Related]
11. X-linked adrenoleukodystrophy in a chimpanzee due to an ABCD1 mutation reported in multiple unrelated humans.
Curiel J; Steinberg SJ; Bright S; Snowden A; Moser AB; Eichler F; Dubbs HA; Hacia JG; Ely JJ; Bezner J; Gean A; Vanderver A
Mol Genet Metab; 2017 Nov; 122(3):130-133. PubMed ID: 28919002
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Functions in Adult-Onset Phenotypes of X-Linked Adrenoleukodystrophy.
Schäfer L; Roicke H; Fischer M; Sühnel A; Köhler W
Ann Neurol; 2021 Aug; 90(2):266-273. PubMed ID: 34105176
[TBL] [Abstract][Full Text] [Related]
13. Auditory brainstem response findings and peripheral auditory sensitivity in adrenoleukodystrophy.
Pillion JP; Kharkar S; Mahmood A; Moser H; Shimizu H
J Neurol Sci; 2006 Sep; 247(2):130-7. PubMed ID: 16737712
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of Clinical and Imaging Characteristics of 48 X-Linked Adrenoleukodystrophy Patients: Our Experience from a University Hospital.
Bhat M; Natarajan A; Chandra SR; Christropher R; Netravathi M
Neurol India; 2022; 70(4):1554-1561. PubMed ID: 36076658
[TBL] [Abstract][Full Text] [Related]
15. Retrospective evaluation of patients with X-linked adrenoleukodystrophy with a wide range of clinical presentations: a single center experience.
Olgac A; Kasapkara ÇS; Derinkuyu B; Yüksel D; Çetinkaya S; Aksoy A; Ceylaner S; Güleray N; Yeşilipek A; Aydın Hİ; Orgun LT; Kılıç M
J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1169-1179. PubMed ID: 34162029
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis and genotype-phenotype correlation of 29 unrelated Japanese patients with X-linked adrenoleukodystrophy.
Takano H; Koike R; Onodera O; Sasaki R; Tsuji S
Arch Neurol; 1999 Mar; 56(3):295-300. PubMed ID: 10190819
[TBL] [Abstract][Full Text] [Related]
17. Clinical, neuroimaging, biochemical, and genetic features in six Chinese patients with Adrenomyeloneuropathy.
Li J; Wang H; He Z; Wang X; Tang J; Huang D
BMC Neurol; 2019 Sep; 19(1):227. PubMed ID: 31526374
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy.
Turk BR; Theisen BE; Nemeth CL; Marx JS; Shi X; Rosen M; Jones RO; Moser AB; Watkins PA; Raymond GV; Tiffany C; Fatemi A
JAMA Neurol; 2017 May; 74(5):519-524. PubMed ID: 28288261
[TBL] [Abstract][Full Text] [Related]
19. Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy.
de Beer M; Engelen M; van Geel BM
Neurology; 2014 Dec; 83(24):2227-31. PubMed ID: 25378668
[TBL] [Abstract][Full Text] [Related]
20. Therapy of X-linked adrenoleukodystrophy.
Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
